Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

10832	Companies
235108	Keywords
163997	Articles
125884	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 03/26/2025 at 14:25, 1 year 4 months ago

Jaguar Health CEO, Board Members, Other C-Suite Members, and Institutional and Accredited Investors Invest in $3.448 Million Bridge Financing Priced At-The-Market Under Nasdaq Rules
Jaguar Health, Inc. announced a private placement of convertible promissory notes to selected investors for working capital. H.C. Wainwright & Co. is the placement agent

Private Placement Working Capital Convertible Notes Jaguar Health Inc. H.C. Wainwright & Co.
BRIEF

published on 03/18/2025 at 13:35, 1 year 4 months ago

Jaguar Health Announces Reverse Stock Split

Reverse Stock Split Jaguar Health Nasdaq Compliance Institutional Investors Equiniti Trust
BRIEF

published on 03/18/2025 at 13:35, 1 year 4 months ago

Jaguar Health annonce un regroupement d'actions inversé

Investisseurs Institutionnels Jaguar Health Regroupement D'actions Conformité NASDAQ Equiniti Trust
PRESS RELEASE

published on 03/18/2025 at 13:30, 1 year 4 months ago

Jaguar Health, Inc. Announces Reverse Stock Split
Jaguar Health, Inc. announces reverse stock split approval at Special Meeting of Stockholders to comply with Nasdaq's listing standards. Shares to trade on split-adjusted basis starting March 24, 2025

Shareholders Reverse Stock Split Nasdaq Listing Jaguar Health Stock Market
BRIEF

published on 03/13/2025 at 21:20, 1 year 4 months ago

Jaguar Health Approves Proposals and Anticipates Key Developments in 2025

Crofelemer Clinical Trials Jaguar Health Regulatory Approval Rare Diseases
BRIEF

published on 03/13/2025 at 21:20, 1 year 4 months ago

Jaguar Health approuve les propositions et anticipe les développements clés en 2025

Crofelemer Jaguar Health Essais Cliniques Maladies Rares Approbation Réglementaire
PRESS RELEASE

published on 03/13/2025 at 21:15, 1 year 4 months ago

Jaguar Health Reports Approval of All Proposals at March 2025 Special Meeting of Stockholders
Jaguar Health announces voting results of Special Meeting of Stockholders and expect first results in Q2 2025 for crofelemer trials in rare diseases. FDA meeting anticipated for Phase 3 OnTarget trial in breast cancer patients

Special Meeting Jaguar Health Rare Diseases Crofelemer Trials FDA Meeting
BRIEF

published on 02/27/2025 at 14:35, 1 year 5 months ago

Jaguar Health Implements Stockholder Rights Plan Amid Acquisition Interest

Biotechnology Jaguar Health Crofelemer Trials FDA Meeting Stockholder Rights Plan
BRIEF

published on 02/27/2025 at 14:35, 1 year 5 months ago

Jaguar Health met en œuvre un plan de protection des droits des actionnaires dans le cadre d'une demande d'acquisition

Biotechnologie Santé Jaguar Réunion De La FDA Essais Sur Crofelemer Plan De Droits Des Actionnaires
PRESS RELEASE

published on 02/27/2025 at 14:30, 1 year 5 months ago

Jaguar Health Adopts Limited Duration Stockholder Rights Plan to Ensure Stockholders Can Realize Long-Term Value
Jaguar Health, Inc. announces results of crofelemer trials for rare diseases and adoption of Rights Plan to deter open-market accumulation. FDA meeting expected in Q2 2025 for breast cancer study results

Jaguar Health Crofelemer Trials FDA Meeting Rights Plan Breast Cancer Study

Accesswire

Published on 08/13/2026 at 19:55, 8 minutes ago

NuRAN Wireless Receives Nasdaq Approval to List on The Nasdaq Capital Market; Trading Expected to Commence August 17, 2026 and C$7.6 Million Financing to Close August 14, 2026
Published on 08/13/2026 at 17:55, 2 hours 8 minutes ago

Alset AI Announces Agreement to Sell 9.9% Interest in Lyken AI Computing to FingerMotion
Published on 08/13/2026 at 14:31, 5 hours 32 minutes ago

Wi2Wi Announces Strategic Equipment Investments to Expand Production Capacity
Published on 08/13/2026 at 14:15, 5 hours 48 minutes ago

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th
Published on 08/13/2026 at 14:00, 6 hours 3 minutes ago

AEONIAN Expands Koocanusa Copper Project to Approximately 412 Km(2); Fieldwork Underway Across Four New Target Areas

View all ACCESSWIRE

EQS Group

Published on 08/13/2026 at 18:17, 1 hour 45 minutes ago

EQS-Adhoc: Energiekontor AG: Energiekontor adjusts earnings guidance for the 2026 financial year
Published on 08/13/2026 at 18:00, 2 hours 2 minutes ago

Issue of Equity
Published on 08/13/2026 at 18:00, 2 hours 2 minutes ago

Deutsche EuroShop reports good operational performance in the first half of 2026 and confirms its forecast
Published on 08/13/2026 at 17:50, 2 hours 12 minutes ago

EQS-Adhoc: NFON AG updates guidance for the 2026 financial year
Published on 08/13/2026 at 17:23, 2 hours 39 minutes ago

EQS-Adhoc: Sirma Group JSC: Signing of Agreements to Acquire a Majority Stake in Jucari Global Pty Ltd

Les Echos

Published on 08/13/2026 at 18:00, 2 hours 3 minutes ago

Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 2 days 2 hours ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 2 days 2 hours ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 3 days 2 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 3 days 2 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026

View all LES ECHOS COMFI WIRE